← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2013Last known activity
Jun 1, 2020
Timeline
2010s
- Jan 1, 2013
Myanmar Oxford Clinical Research Unit— Founded
Drugs by trial phase (6 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT04210141Lead sponsorPhase 2Jun 1, 2020
- NCT02020330Overall official - principal investigatorPhase 3Jan 1, 2014
- NCT01872702CollaboratorN/AApr 1, 2013
Details
- Founded
- MM Jan 1, 2013
- Last known activity
- Jun 1, 2020